These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 307270)

  • 1. Urinary excretion of porphyrins in two cases of porphyria cutanea tarda during a period of various treatments.
    Eriksen L; Thune PO
    Scand J Clin Lab Invest; 1978 May; 38(3):273-7. PubMed ID: 307270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follow-up studies of porphyrin excretion in porphyria cutanea tarda treated with p-aminobenzoic acid.
    de Salamanca RE; Peña ML; Olmos A; Molina C; Ladero JM
    Ann Clin Res; 1980 Dec; 12(6):279-81. PubMed ID: 6972189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Porphyria cutanea tarda: possible treatment and its results (author's transl)].
    Goerz G; Krieg T
    Dtsch Med Wochenschr; 1978 Aug; 103(34):1329-33. PubMed ID: 308001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of porphyrin-excretion in female estrogen-induced porphyria cutanea tarda.
    Enríquez de Salamanca R; Mingo D; Chinarro S; Muñoz JJ; Perpiñá J
    Arch Dermatol Res; 1982; 274(1-2):179-84. PubMed ID: 7165364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Letter: Porphyria cutanea tarda: normalization of porphyrin-excretion following treatment with p-amino-benzoic acid (Potaba) (author's transl)].
    Goerz G; Krieg T; Bolsen K
    Arch Dermatol Res (1975); 1976 Jun; 255(3):331-5. PubMed ID: 942260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of pyridoxal-5-phosphate on porphyrin excretion and serum iron level in porphyria cutanea tarda.
    Petres J; Schröder K; Consbruch U; Ladner HA
    Ger Med Mon; 1968 Feb; 13(2):73-6. PubMed ID: 4871194
    [No Abstract]   [Full Text] [Related]  

  • 7. [Porphyrin excretion and blood iron under pyridoxal-5-phosphate administration in porphria cutanea tarda].
    Petres J; Schröder K; Consbruch U; Ladner HA
    Dtsch Med Wochenschr; 1967 Aug; 92(34):1498-502. PubMed ID: 6047898
    [No Abstract]   [Full Text] [Related]  

  • 8. [3 cases of porphyria cutanea tarda--change of urinary porphyrin excretion patterns after phlebotomy].
    Murayama F; Ohgami T; Honda T; Rikimaru M; Hirowatari T; Nonaka S; Yoshida H
    Nihon Hifuka Gakkai Zasshi; 1983 Aug; 93(9):909-15. PubMed ID: 6663799
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of porphyria cutanea tarda with chloroquine and phlebotomy.
    Swanbeck G; Wennersten G
    Br J Dermatol; 1977 Jul; 97(1):77-81. PubMed ID: 889703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Accident in treatment of porphyria cutanea tarda by chloroquine (Resochin) (author's transl)].
    Goerz G; Krieg T; Eichenauer MG
    Arch Dermatol Res (1975); 1976 Apr; 255(2):169-76. PubMed ID: 1275551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of phlebotomy on urinary porphyrin pattern and liver histology in patients with porphyria cutanea tarda.
    Di Padova C; Marchesi L; Cainelli T; Gori G; Podenzani SA; Rovagnati P; Rizzardini M; Cantoni L
    Am J Med Sci; 1983; 285(1):2-12. PubMed ID: 6824014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-standing changes in the urinary profile of porphyrin isomers after clinical remission of porphyria cutanea tarda.
    To-Figueras J; Ozalla D; Mateu CH
    Ann Clin Lab Sci; 2003; 33(3):251-6. PubMed ID: 12956438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inheritance of porphyria cutanea tarda. Analysis of 14 cases in 5 families.
    Topi G; D'Alessandro Gandolfo L
    Br J Dermatol; 1977 Dec; 97(6):617-27. PubMed ID: 603745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary porphyrin excretion in various types of porphyria. Thin-layer chromatographic study.
    Perrot H; Boucherat M; Gardella C
    Dermatologica; 1980; 161(3):167-78. PubMed ID: 7398995
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of bloodletting on the excretion of porphyrius and clelta aminolevulinic acid as well as the clinical picture of porphyria cutanea tarda].
    Broese I; Mattheus A
    Dermatol Monatsschr; 1977 Feb; 163(2):111-8. PubMed ID: 858437
    [No Abstract]   [Full Text] [Related]  

  • 17. Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.
    Gross U; Honcamp M; Daume E; Frank M; Düsterberg B; Doss MO
    Horm Metab Res; 1995 Aug; 27(8):379-83. PubMed ID: 7590628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of serum and urinary porphyrin levels in porphyria cutanea tarda.
    Kalb RE; Grossman ME; Poh-Fitzpatrick MB
    Arch Dermatol; 1985 Oct; 121(10):1289-91. PubMed ID: 4037823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Familial porphyria cutanea tarda: the pattern of porphyrins formed from porphobilinogen by hemolysates.
    Alleman MA; Wilson JH; van den Berg JW; Edixhoven-Bosdijk A; van Gastel-Quist LM
    Clin Chem; 1982 May; 28(5):1144-7. PubMed ID: 7074894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between levels of free and protein-bound plasma porphyrin and urinary porphyrins in porphyria cutanea tarda.
    Moran MJ; Fontanellas A; Santos JL; Enriquez de Salamanca R
    Int J Biochem Cell Biol; 1995 Jun; 27(6):585-8. PubMed ID: 7671136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.